These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2858723)

  • 21. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure.
    Watson AJ; Keogh JA
    Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostatic and fibrinolytic response to nasal desmopressin in hemodialysis patients.
    Ulusoy S; Ovali E; Aydin F; Erem C; Ozdemir F; Kaynar K
    Med Princ Pract; 2004; 13(6):340-5. PubMed ID: 15467309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
    Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
    Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor.
    Teng R; Mitchell PD; Butler K
    J Clin Pharm Ther; 2014 Apr; 39(2):186-91. PubMed ID: 24444280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
    Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal biopsy in patients with acute renal failure and prolonged bleeding time.
    Gotti E; Mecca G; Valentino C; Cortinovis E; Bertani T; Remuzzi G
    Lancet; 1984 Oct; 2(8409):978-9. PubMed ID: 6149363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Desmopressin acetate - a new antidiuretic].
    S Afr Med J; 1979 Jan; 55(1):2. PubMed ID: 424908
    [No Abstract]   [Full Text] [Related]  

  • 28. Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
    Triulzi DJ; Blumberg N
    Yale J Biol Med; 1990; 63(1):1-7. PubMed ID: 2113328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombocytic alpha-delta-storage-pool-disease: shortening of bleeding time after infusion of 1-desamino-8-D-arginine vasopressin].
    Kosch A; Kehrel B; Nowak-Göttl U; Häberle J; Jürgens H
    Klin Padiatr; 1999; 211(4):198-200. PubMed ID: 10472549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of deamino-8-D-arginine vasopressin on urinary prostaglandins E2 and F2 alpha excretion.
    Walker L; Frölich JC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1107-9. PubMed ID: 7369023
    [No Abstract]   [Full Text] [Related]  

  • 31. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) in normal individuals (author's transl)].
    Takahashi H; Itoh M; Kobayashi I; Hattori A; Takahashi K; Sakuragawa N; Shibata A; Tsukada T
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):907-17. PubMed ID: 6785953
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 34. Vasopressin analog (DDAVP) facilitates concept learning in human males.
    Beckwith BE; Petros T; Kanaan-Beckwith S; Couk DI; Haug RJ; Ryan C
    Peptides; 1982; 3(4):627-30. PubMed ID: 7134030
    [No Abstract]   [Full Text] [Related]  

  • 35. 1-Deamino-8-D-arginine vasopressin lowers protein C activity in uremics.
    Aunsholt NA; Schmidt EB; Stoffersen E
    Nephron; 1989; 53(1):6-8. PubMed ID: 2506477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    N Engl J Med; 1984 Mar; 310(11):722-3. PubMed ID: 6608051
    [No Abstract]   [Full Text] [Related]  

  • 37. Desmopressin and sheared platelets: a test.
    O'Brien JR; Green PJ; Salmon GP
    Lancet; 1988 Mar; 1(8586):655. PubMed ID: 2894592
    [No Abstract]   [Full Text] [Related]  

  • 38. 1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure.
    Watson AJ; Keogh JA
    Am J Nephrol; 1984; 4(1):49-51. PubMed ID: 6731500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 40. DDAVP, cryoprecipitate, and highly 'purified' factor VIII concentrate in uremia.
    Juhl A
    Nephron; 1986; 43(4):305-6. PubMed ID: 3090461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.